Kinnate Biopharma Inc. reported raising $74.5 Million in an initial SEC Form D filing, from an offering of $74.5 Million
Amount Raised
$74.5 Million
Round Type
Venture
Quick answer
Kinnate Biopharma raised $74.5 Million in a funding round, dated December 23, 2019. Kinnate Biopharma is based in San Diego, California, United States.
- How much did Kinnate Biopharma raise?
- Kinnate Biopharma raised $74.5 Million in a funding round on December 23, 2019.
- What does Kinnate Biopharma do?
- Kinnate Biopharma Inc. is a clinical-stage precision oncology company focused on expanding on the promise of targeted therapies for those battling cancer.
- Where is Kinnate Biopharma based and how big is it?
- Kinnate Biopharma is based in San Diego, California, United States.
Source: Fundz verified event record.
Who else raised in Healthcare and Medical around the same time
Companies in the same sectors as Kinnate Biopharma that raised within 45 days of this round, from Fundz verified event records.
- Immuneering raised $20M on January 27, 2020.
- Damora Therapeutics, Inc. raised $79M on January 16, 2020.
- Savara Inc raised $27M on January 2, 2020.
- Flyte raised $1.1M (Seed) on February 5, 2020.
- Vaccinex raised $7.5M on February 3, 2020.
- Aethlon Medical raised $2.7M on January 24, 2020.
Who to call at Kinnate Biopharma, and when
A new round usually means Kinnate Biopharma is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Kinnate Biopharma raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Kinnate Biopharma, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Kinnate Biopharma. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Kinnate Biopharma raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Kinnate Biopharma raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.